LKFT NASDAQ
Galapagos N.V. Sponsored ADR
1W: +1.0%
YTD: -2.5%
$27.49
-0.28 (-1.01%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.8B
52W Range26.42-37.78
Volume123,460
Avg Volume166,896
Beta0.12
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOHenry O. Gosebruch
Employees452
SectorHealthcare
IndustryBiotechnology
IPO Date2005-05-05
Websitegalapagos.com
Mechelen
US
About Galapagos N.V. Sponsored ADR
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Latest News
No recent news
Recent Insider Trades
No insider trades found